Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic encephalopathy.

Roger F Butterworth1

  • 1Neuroscience Research Unit, CHUM (Hôpital Saint-Luc), Montreal, Canada.

Alcohol Research & Health : the Journal of the National Institute on Alcohol Abuse and Alcoholism
|November 13, 2004
PubMed
Summary

Hepatic encephalopathy (HE) is a liver failure complication causing brain dysfunction due to toxin buildup like ammonia and manganese. Treatments aim to reduce toxins, manage brain effects, support liver function, or use liver transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2.

Frontiers in neuroscience·2023
Same author

Potential for the Repurposing of Adamantane Antivirals for COVID-19.

Drugs in R&D·2021
Same author

Ammonia Removal by Metabolic Scavengers for the Prevention and Treatment of Hepatic Encephalopathy in Cirrhosis.

Drugs in R&D·2021
Same author

Region-selective permeability of the blood-brain barrier to α-aminoisobutyric acid during thiamine deficiency and following its reversal.

Metabolic brain disease·2020
Same author

The Role of Liver Disease in Alcohol-Induced Cognitive Defects.

Alcohol health and research world·2019
Same author

Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis.

Metabolic brain disease·2019

Area of Science:

  • Neuroscience
  • Hepatology
  • Toxicology

Background:

  • Hepatic encephalopathy (HE) is a neurological complication of chronic liver failure, often seen in alcohol-related cirrhosis.
  • Reduced liver function leads to toxin accumulation, including ammonia and manganese, in the bloodstream.
  • These toxins can cross the blood-brain barrier, impacting neuronal and astrocyte function.

Purpose of the Study:

  • To elucidate the mechanisms of brain damage in hepatic encephalopathy.
  • To investigate the roles of ammonia and manganese in HE-associated neurotoxicity.
  • To outline current and potential therapeutic strategies for HE.

Main Methods:

  • Positron emission tomography (PET) to quantify brain ammonia levels.
  • Magnetic resonance imaging (MRI) to assess manganese deposition in specific brain regions.
  • Review of existing literature on HE pathophysiology and treatment.

Main Results:

  • Elevated ammonia levels detected in the brains of HE patients, correlating with altered gene expression.
  • Manganese deposition observed in the globus pallidus, linked to characteristic astrocyte structural changes.
  • Identification of key neurotoxic pathways involving ammonia and manganese.

Conclusions:

  • Ammonia and manganese accumulation are critical factors in the neurotoxicity observed in hepatic encephalopathy.
  • Targeting these toxins and their effects is crucial for managing HE.
  • Liver transplantation remains a definitive treatment option for end-stage liver disease with HE.

Related Experiment Videos